NASDAQ: OKYOOkyo Pharma Ltd Stock Ownership - Who owns Okyo Pharma?
Insider buying vs selling
Have Okyo Pharma Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gabriele M. Cerrone | Executive Chairman | 2023-10-27 | 70,071 | $1.50 | $105.11kBuy |
| Gabriele M. Cerrone | Executive Chairman | 2023-10-23 | 499,468 | $1.50 | $749.20kBuy |
| John P. Brancaccio | Director | 2023-09-15 | 16,670 | $1.50 | $25.01kBuy |
OKYO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OKYO insiders and whales buy or sell their stock.
OKYO Shareholders
What type of owners hold Okyo Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gabriele M. Cerrone | 2,161.60% | 552,359,118 | $828.54M | Insider |
| Barclays PLC | 2.97% | 758,333 | $1.14M | Institution |
| Susquehanna International Group LLP | 0.14% | 34,784 | $52.18k | Institution |
| John P. Brancaccio | 0.07% | 16,670 | $25.01k | Insider |
| Morgan Stanley | 0.05% | 13,846 | $20.77k | Institution |
| Gary S. Jacob | 0.05% | 12,500 | $18.75k | Insider |
| Cerity Partners LLC | 0.05% | 12,312 | $18.47k | Institution |
| Geode Capital Management LLC | 0.05% | 12,090 | $18.14k | Institution |
| Hsbc Holdings PLC 1 | 0.05% | 11,933 | $17.90k | Institution |
| Renaissance Technologies LLC | 0.05% | 11,800 | $17.70k | Institution |
OKYO vs Biotech Stocks
Okyo Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.